The mysteries of mantle cell lymphoma - Do PET scans provide a clue?

Leukemia and Lymphoma

Volumn 49, Issue 9, 2008, Pages 1662-1663

  Link, Brian K ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; DACARBAZINE; DOXORUBICIN; ENZASTAURIN; EVEROLIMUS; FLUORODEOXYGLUCOSE F 18; INTERFERON; LENALIDOMIDE; RITUXIMAB; VINBLASTINE;

B CELL LYMPHOMA; CANCER ADJUVANT THERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE FREE SURVIVAL; HODGKIN DISEASE; HUMAN; INTERMETHOD COMPARISON; LARGE CELL LYMPHOMA; LEUKEMIA RELAPSE; MANTLE CELL LYMPHOMA; MULTIPLE CYCLE TREATMENT; NOTE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

HUMANS; LYMPHOMA, MANTLE-CELL; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS;

EID: 52349090404     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802382780     Document Type: Note

References (8)

1. Harris, N. L., Jaffe, E. S. Stein, H. et al. (1994) A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood, 84, pp. 1361-1392.
2. Zelenetz, A. D., Advani, R. H. Byrd, J. C. et al. (2008) Non-Hodgkin's Lymphoma Clinical Practice Guidelines in Oncology (V.3.2008). J natl Compr Cancer Netw, 6, pp. 356-421.
3. Juweid, M. E., Stroobants, S. Hoekstra, O. S. et al. (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol, 25, pp. 571-578.
4. Brepoels, L., Stroobants, S., De Wever, W., Dierickx, D., Vandenberghe, P. Thomas, J. et al. (2008) Positron emission tomography (PET) in mantle cell lymphoma. Leuk Lymphoma, 49, pp. 1693-1701.
5. Cheson, B. D., Pfistner, B. Juweid, M. E. et al. (2007) Revised response criteria for malignant lymphoma. J Clin Oncol, 25, pp. 579-586.
6. Kasamon, Y. L., Wahl, R. L. Ziessman, H. A. et al. (2007) Risk-adapted therapy of aggressive lymphoma based on FDG-PET performed after 2 or 3 cycles of initial chemotherapy. Blood, 110, p. 1894a.
7. Moskowitz, C., Hamlin, P. A. Horwitz, S. M. et al. (2006) Phase II Trial of dose-dense R-CHOP followed by risk-adapted consolidation with either ICE or ICE and ASCT, based upon the results of biopsy confirmed abnormal interim restaging PET scan, improves outcome in patients with advanced stage DLBCL. Blood, 108, p. 532a.
8. Kasamon, Y. L. and Wahl, R. L. (2008) FDG PET and risk-adapted therapy in Hodgkin's and non-Hodgkin's lymphoma. Curr Opin Oncol, 20, pp. 206-219.